Dupont Capital Management’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-7,133
| Closed | -$909K | – | 1237 |
|
|
2022
Q4 | $909K | Sell |
7,133
-1,594
| -18% | -$185K | 0.04% | 399 |
|
|
2022
Q3 | $912K | Buy |
8,727
+7,458
| +588% | +$818K | 0.05% | 438 |
|
|
2022
Q2 | $133K | Buy |
+1,269
| New | +$151K | 0.01% | 1119 |
|
|
2022
Q1 | – | Sell |
-1,412
| Closed | -$174K | – | 1788 |
|
|
2021
Q4 | $174K | Sell |
1,412
-1,038
| -42% | -$136K | 0.01% | 1168 |
|
|
2021
Q3 | $348K | Sell |
2,450
-2,368
| -49% | -$348K | 0.01% | 1030 |
|
|
2021
Q2 | $752K | Sell |
4,818
-2,695
| -36% | -$437K | 0.02% | 751 |
|
|
2021
Q1 | $1.17M | Sell |
7,513
-1,830
| -20% | -$283K | 0.03% | 529 |
|
|
2020
Q4 | $1.4M | Sell |
9,343
-3,646
| -28% | -$515K | 0.03% | 437 |
|
|
2020
Q3 | $1.72M | Sell |
12,989
-1,147
| -8% | -$150K | 0.04% | 338 |
|
|
2020
Q2 | $1.64M | Sell |
14,136
-19,613
| -58% | -$2.26M | 0.04% | 360 |
|
|
2020
Q1 | $3.31M | Buy |
33,749
+13,439
| +66% | +$1.76M | 0.08% | 184 |
|
|
2019
Q4 | $2.95M | Buy |
20,310
+5,377
| +36% | +$742K | 0.07% | 257 |
|
|
2019
Q3 | $1.99M | Sell |
14,933
-4,137
| -22% | -$534K | 0.05% | 338 |
|
|
2019
Q2 | $2.18M | Sell |
19,070
-5,695
| -23% | -$667K | 0.05% | 356 |
|
|
2019
Q1 | $3.07M | Sell |
24,765
-33,887
| -58% | -$3.85M | 0.07% | 264 |
|
|
2018
Q4 | $5.91M | Sell |
58,652
-7,316
| -11% | -$823K | 0.14% | 129 |
|
|
2018
Q3 | $8.42M | Sell |
65,968
-2,560
| -4% | -$304K | 0.19% | 99 |
|
|
2018
Q2 | $7.41M | Sell |
68,528
-19,383
| -22% | -$2.11M | 0.18% | 104 |
|
|
2018
Q1 | $9.31M | Sell |
87,911
-2,363
| -3% | -$274K | 0.22% | 81 |
|
|
2017
Q4 | $10.6M | Buy |
90,274
+3,422
| +4% | +$387K | 0.24% | 75 |
|
|
2017
Q3 | $9.87M | Sell |
86,852
-3,303
| -4% | -$381K | 0.22% | 85 |
|
|
2017
Q2 | $11.2M | Sell |
90,155
-3,944
| -4% | -$468K | 0.25% | 79 |
|
|
2017
Q1 | $11.2M | Buy |
94,099
+61,530
| +189% | +$6.97M | 0.25% | 77 |
|
|
2016
Q4 | $3.26M | Buy |
32,569
+17,894
| +122% | +$1.92M | 0.07% | 222 |
|
|
2016
Q3 | $1.85M | Buy |
+14,675
| New | +$1.81M | 0.04% | 318 |
|
|
2015
Q1 | – | Sell |
-6,276
| Closed | -$691K | – | 641 |
|
|
2014
Q4 | $691K | Buy |
6,276
+503
| +9% | +$53K | 0.01% | 519 |
|
|
2014
Q3 | $564K | Buy |
5,773
+3,054
| +112% | +$300K | 0.01% | 546 |
|
|
2014
Q2 | $274K | Hold |
2,719
| – | – | ﹤0.01% | 615 |
|
|
2014
Q1 | $250K | Hold |
2,719
| – | – | ﹤0.01% | 608 |
|
|
2013
Q4 | $246K | Buy |
2,719
+1,081
| +66% | +$93.5K | ﹤0.01% | 584 |
|
|
2013
Q3 | $131K | Sell |
1,638
-10,482
| -86% | -$825K | ﹤0.01% | 587 |
|
|
2013
Q2 | $882K | Buy |
+12,120
| New | +$906K | 0.02% | 481 |
|
Other funds holding ZBH
Dupont Capital Management's ZBH Position: Q1 2023 in Review
Dupont Capital Management sold out of Zimmer Biomet (ZBH) in Q1 2023, closing a stake of 7,133 shares — an estimated $909K sold.
Dupont Capital Management first reported a position in ZBH in Q2 2013 and held it in 32 quarters. The position peaked at $11.2M in Q2 2017. 993 funds tracked by Wall St. Rank hold ZBH as of Q1 2023.
- Dupont Capital Management reported no remaining Zimmer Biomet position as of Q1 2023 after selling out during the quarter.
- Dupont Capital Management sold 7,133 Zimmer Biomet shares in Q1 2023, an estimated $909K.
- Dupont Capital Management first reported a position in Zimmer Biomet in Q2 2013 and held it in 32 quarters.
- Dupont Capital Management's Zimmer Biomet position peaked at $11.2M in Q2 2017.
- 993 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2023.
Based on Dupont Capital Management's 13F filing for Q1 2023, filed 28 Apr 2023.